Past Program (2004)
Joint meeting of the Montagna Symposium on the Biology of Skin and
the 6th International Skin Carcinogenesis Conference
 
Keratinocyte and Melanocyte Cancers of Skin: 
Interacting Pathways
October 15-19, 2004
Salishan Lodge, Gleneden Beach, Oregon
 
FRIDAY, OCTOBER 15  
Opening Reception, Keynote Speakers  
Brian Druker, Oregon Health & Science University Lessons from hematologic malignancy
Meenhard Herlyn, University of Pennsylvania Cell-cell communications for melanocytes and melanoma cells
   
SATURDAY, OCTOBER 16  
Breakfast  
Neil Swanson, Oregon Health & Science University; Molly Kulesz-Martin, Oregon Health & Science University; Jackie Bickenbach, University of Iowa Welcome and Introductions
   
Multi-Stage Carcinogenesis  
John DiGiovanni, UT MD Anderson Cancer Center The role of Stat3 in carcinogenesis
James G. Rheinwald, Harvard Medical School Co-expression of p16INK4A and laminin 5 gamma 2 in keratinocytes: a normal wound healing response that goes awry during neoplastic progression to carcinoma
Claudio Conti, UT MD Anderson Cancer Center Cell cycle regulation and skin tumorigenesis: Lessons from genetically-engineered mice
Glenn Merlino, National Cancer Institute Creating UV responsive, genetically tractable mouse models of cutaneous melanoma
Coffee Break  
Petra Boukamp, German Cancer Research Center The role of Telomerase- and telomeres in normal epidermis and carcinogenesis
Jack Longley, University of Wisconsin Keratinocyte SCF and melanocyte KIT signalling
Neil F. Box, Baylor College of Medicine The Sooty Foot Ataxia mouse: A new model for p53 pathway melanoma?
David Greenhalgh, Glasgow University Inducible cre-mediated N-ras activation and PTEN inactivation in transgenic mouse epidermal keratinocytes elicits melanocyte hyperplasia in papillomas
Lunch Break  
   
Basal Cell/Metabolic Paths  
Andrzej Dlugosz, University of Michigan Hedgehog signaling requirements in hair follicles and basal cell carcinomas
Rune Toftgård, Karolinska Institute NFkB pathway in epidermal cell carcinoma
Marcel Huber, Lausanne University The tumor suppressor CYLD interacts with TRIP and regulates negatively NF-kB activation by cytokines
Coffee Break  
Susan M. Fischer, UT MD Anderson Cancer Center Are prostaglandins necessary for skin cancer development?
Tatiana M. Oberyszyn, The Ohio State University Immunosuppression, inflammation and skin cancer
Stephen E. Ulrich, UT MD Anderson Cancer Center A role for Platelet activating factor receptor binding in UV-induced immune suppression and skin cancer induction
Richard Eckert, Case School of Medicine PKCd regulates keratinocyte death and survival by regulating activity and subcellular localization of a p38d-ERK1/2 complex
Ajit K. Verma, University of Wisconsin Tumor necrosis factor a is linked to the susceptibility of protein kinase C e transgenic mice to ultraviolet radiation-induced cutaneous damage and development of squamous cell carcinomas
Mitchell F. Denning, Loyola University Medical Center Regulation of melanoma growth by protein kinase C isoforms
   
Announcements  
Break  
Banquet Dinner: Neil Swanson, MD, Oregon Health & Science University Introductions and Thank you's

Banquet Dinner: Albert M. Kligman, MD, PhD, Foundation for Basic Cutaneous Research

Bill Montagna and the shaping of dermatology through the Montagna Symposium
Banquet Dinner: Fran Storrs, MD, Oregon Health & Science University John Storrs and the building of Salishan Lodge: A remembrance
   
SUNDAY, OCTOBER 17  
Breakfast  
Coastal hills hike – or optional free time 
Lunch Break  
   
Intra-Intercellular Signalling  
Brian J. Nickoloff, Loyola University Medical Center Role of notch signaling in melanoma pathogenesis and treatment
Stuart Yuspa, National Cancer Institute CLIC4, an intracellular chloride channel protein, is a novel molecular target for cancer therapy
Steven L. Jacques, Oregon Health & Science University Optical imaging of skin using confocal microscopy, optical coherence tomography and a polarized light camera
Barbara Bedogni, Stanford University Akt and Hypoxia synergize in transforming melanocytes: role of the translation initiation machinery and HIF1a
Coffee Break  
Anne E. Cress, Stanford University Disruption of a delicate balance: Integrin clipping during human tumor progression
Rosemary J. Akhurst, UCSF Comprehensive Cancer Center Genetic interactions between Tgfb1 and Tgfbm3 contribute to risk of skin cancer in mice
Adam Glick, National Cancer Institute Benign and malignant mouse epidermal squamous tumors have discordant transcriptional responses to TGFb1 in vivo
Xiao-Jing Wang, Oregon Health & Science University The role of TGFb1 on skin inflammation: Implication in skin cancer promotion
   
Jackie Bickenbach, University of Iowa 2004 Farber Awards presentation 
Poster Session/Reception Ervin Epstein, Andrew Blauvelt, guides
   
MONDAY, OCTOBER 18  
Breakfast  
   
Growth/Differentiation/Apoptosis/p53  
Jingwu Xie, UT Medical Branch at Galveston Inhibition of Smoothened Signaling Prevents Ultraviolet B (UVB)-Induced Basal Cell Carcinomas through Regulation of Fas Expression and Apoptosis
Hua Lu, Oregon Health & Science University SSRP1 regulates TAp63 functions
Wendy Weinberg, Food & Drug Administration p63 isotype roles in epidermal homeostasis
Maria S. Soengas, University of Michigan Rational design of novel small molecules that shift the mode of action of mapk inhibitors from cell cycle arrest to apoptosis in aggressive melanoma cells
Mihail Iordanov, Oregon Health & Science University Apoptotic keratinocytes secrete mitogenic factors: Implications for eczemas and cancer
Coffee Break  
Dennis Roop, Baylor College of Medicine Genes which alter stem cell fate or commitment to a stratified epithelial lineage influence susceptibility to skin cancer and tumor phenotype
Frank McKeon, Harvard Medical School Role of p63 in the maintenance of epidermal progenitor cells
Lunch Break  
   
Prevention  
Zigang Dong, University of Minnesota JNK and skin carcinogenesis
Connie B. Lin, J&J CPPW Skin Research Center The inhibitory effect of topical applications of non-denatured soy extracts on UVB-induced erythema, DNA damage, and apoptosis, and on the formation and growth of skin tumors
Jill C. Pelling, Northwestern University School of Medicine UVB-induced COX-2 transcription in mouse keratinocytes requires the Ebox, ATF/CRE and NF-IL6 responsive elements and is inhibited by the bioflavonoid apigenin
Therapeutics  
R. Stephen Lloyd, Oregon Health & Science University Enhanced repair of UV-induced DNA damage by targeting the T4 pyrimidine dimer glycosylase to the nucleus of mammalian cells
Philip Stork, Oregon Health & Science University TBA
Barbara A. Gilchrest, Boston University School of Medicine Using telomere-based DNA damage responses to prevent and treat skin cancer
   
Ervin Epstein, University of California San Francisco, and Barbara A. Gilchrest, Boston University School of Medicine Break out session strategy and instructions
Coffee Break  
Clinician break-out sessions* Bridging the basic signaling pathways in skin cancer development to clinical applications in detection, prognosis and molecular targeted treatment
Clinician break-out session reports *  
Break  
Salmon Bake on the beach  
   
TUESDAY, OCTOBER 19  
Breakfast  
   
Etiology/Interactive Paths  
Rebecca J. Morris, Columbia University Isolation, profiling, and fate-determination of keratinocyte stem cells from the hair follicle bulge
Irina Budunova, Northwestern University Stem cells and signaling in skin cancer
Aaron P. Jansen, National Cancer Institute Transgenic expression in mice of the translation inhibitor, Pdcd4, demonstrates its tumorigenesis suppressor activity
Brandt L. Schneider, Texas Tech UHSC The importance of being big
Coffee Break  
Molly Kulesz-Martin, Oregon Health & Science University Selective DNA binding and transactivation by endogenous p53, p63 or p73 isoforms coordinated with apoptosis in response to DNA damage
G. Tim Bowden, Arizona Cancer Center

UVA mediated signaling pathways in human keratinocytes;
Highlighting keratinocyte paths for future

G. Tim Bowden, Arizona Cancer Center Highlighting keratinocyte paths for future
Meenhard Herlyn, University of Pennsylvania Highlighting melanoma paths for future
   

*The Clinician Breakout sessions will foster interaction in small groups composed of scientific speakers, clinicians speaking or attending the meeting, and a cross section of registrants including Dermatology residents. About 9 groups will be composed of 12-15 persons each, with a discussion facilitator from the Program Committee assigned to each. After discussion, a leader chosen by the group will present a short summary for general discussion among all participants.

 
Co-chairs

Molly Kulesz-Martin, Ph.D.
Jackie R. Bickenbach, Ph.D.


Program Committee

G. Tim Bowden, Arizona Cancer Center
Susan Fischer, UTMD Anderson Cancer Center
Meenhard Herlyn, University of Pennsylvania
Molly Kulesz-Martin, Oregon Health & Science University (Program Chair)
Glenn Merlino, NCI Center for Cancer Research
David Norris (Chair Emeritus), University of Colorado
Philip J.S. Stork, Oregon Health & Science University Vollum Institute
Dennis Roop, Baylor College of Medicine
Xiao-Jing Wang, Oregon Health & Science University
Stuart Yuspa, NCI Center for Cancer Research

 

Last updated: February 10, 2005